Unknown

Dataset Information

β-Cell glucokinase expression was increased in type 2 diabetes subjects with better glycemic control.


ABSTRACT:

Background

Type 2 diabetes (T2D) is characterized by a progressive deterioration of β-cell function with a continuous decline in insulin secretion. Glucokinase (GCK) facilitates the rate-limiting step of glycolysis in pancreatic β-cells, to acquire the proper glucose-stimulated insulin secretion. Multiple glucokinase activators (GKAs) have been developed and clinically tested. However, the dynamic change of human pancreatic GCK expression during T2D progression has not been investigated.

Methods

We evaluated GCK expression by measuring the average immunoreactivity of GCK in insulin+ or glucagon+ cells from pancreatic sections of 11 nondiabetic subjects (ND), 10 subjects with impaired fasting glucose (IFG), 9 with well-controlled T2D (wT2D), and 5 indivi

SUBMITTER: Liu J 

PROVIDER: S-EPMC10172022 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature